BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26085145)

  • 1. Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.
    Wang WH; Kuo CW; Chang LK; Hung CC; Chang TH; Liu ST
    J Virol; 2015 Sep; 89(17):8922-31. PubMed ID: 26085145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interactions of Epstein-Barr virus capsid proteins.
    Wang WH; Chang LK; Liu ST
    J Virol; 2011 Feb; 85(4):1615-24. PubMed ID: 21147928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rta is an Epstein-Barr virus tegument protein that improves the stability of capsid protein BORF1.
    Huang HH; Wang WH; Feng TH; Chang LK
    Biochem Biophys Res Commun; 2020 Mar; 523(3):773-779. PubMed ID: 31948747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Epstein-Barr Virus Minor Capsid Protein BORF1 by TRIM5α.
    Lin LT; Lu YS; Huang HH; Chen H; Hsu SW; Chang LK
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembly of Epstein-Barr virus capsids.
    Henson BW; Perkins EM; Cothran JE; Desai P
    J Virol; 2009 Apr; 83(8):3877-90. PubMed ID: 19158247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL; Kenney S
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.
    Sides MD; Block GJ; Chadwick RW; Shan B; Flemington EK; Lasky JA
    Virol J; 2011 Oct; 8():461. PubMed ID: 21975125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.
    Szekely L; Pokrovskaja K; Jiang WQ; de The H; Ringertz N; Klein G
    J Virol; 1996 Apr; 70(4):2562-8. PubMed ID: 8642686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.
    Sides MD; Block GJ; Shan B; Esteves KC; Lin Z; Flemington EK; Lasky JA
    Virology; 2011 Jul; 416(1-2):86-97. PubMed ID: 21605886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
    Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
    PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JC virus intranuclear inclusions associated with PML-NBs: analysis by electron microscopy and structured illumination microscopy.
    Shishido-Hara Y; Ichinose S; Uchihara T
    Am J Pathol; 2012 Mar; 180(3):1095-1106. PubMed ID: 22266251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.
    Becker KA; Florin L; Sapp C; Maul GG; Sapp M
    J Virol; 2004 Feb; 78(3):1121-8. PubMed ID: 14722267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of intranuclear inclusions of human polyomavirus JC. Capsid proteins are assembled into virions at the PML nuclear bodies].
    Shishido-Hara Y
    Uirusu; 2006 Jun; 56(1):17-25. PubMed ID: 17038808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
    Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
    PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
    Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
    Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.
    Nicewonger J; Suck G; Bloch D; Swaminathan S
    J Virol; 2004 Sep; 78(17):9412-22. PubMed ID: 15308735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.